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Abstract
Cardiomyopathy is a major cause of heart failure and sudden cardiac death; several mutations in sarcomeric protein genes
have been associated with this disease. Our aim in the present study is to investigate the genetic variations in Troponin T
(cTnT) gene and its association with dilated cardiomyopathy (DCM) in south-Indian patients. Analyses of all the exons and
exon-intron boundaries of cTnT in 147 DCM and in 207 healthy controls had revealed a total of 15 SNPs and a 5 bp INDEL; of
which, polymorphic SNPs were compared with the HapMap population data. Interestingly, a novel R144W mutation, that
substitutes polar-neutral tryptophan for a highly conserved basic arginine in cTnT, altering the charge drastically, was
identified in a DCM, with a family history of sudden-cardiac death (SCD). This mutation was found within the tropomyosin
(TPM1) binding domain, and was evolutionarily conserved across species, therefore it is expected to have a significant
impact on the structure and function of the protein. Family studies had revealed that the R144W is co-segregating with
disease in the family as an autosomal dominant trait, but it was completely absent in 207 healthy controls and in 162
previously studied HCM patients. Further screening of the proband and three of his family members (positive for R144W
mutant) with eight other genes b-MYH7, MYBPC3, TPM1, TNNI3, TTN, ACTC, MYL2 and MYL3, did not reveal any disease
causing mutation, proposing the absence of compound heterozygosity. Therefore, we strongly suggest that the novel
R144W unique/private mutant identified in this study is associated with FDCM. This is furthermore signifying the unique
genetic architecture of Indian population.
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Introduction
Dilated cardiomyopathy (DCM: OMIM 115200), is character-
ized by cardiac left ventricular dilation and systolic dysfunction,
affects at least 1 in 2500 individuals [1], and a major cause for
morbidity and mortality [2], including heart failure (HF) and
sudden cardiac death (SCD) [3–5]. Familial DCM (FDCM) is a
genetically heterogeneous disease [6], whereas Idiopathic DCM
(IDCM) is diagnosed when clinically detectable causes of DCM
are excluded. Genetic screening of first-degree relatives had
revealed, approximately 20 to 35% of idiopathic cases, were due to
genetic defects [6–11]. More than 30 nuclear genes, encoding for
sarcomere (contractile apparatus), cytoskeletal and calcium
homeostasis proteins of diverse functions, have been reported to
cause FDCM [6]. To date, mutations in LMNA, MYH7, MYBPC3,
TNNT2, SCN5A, and MYH6 genes have been accounted for
approximately 75% of FDCM [12]. Most of the genes implicated
in genetics of DCM/FDCM follow autosomal dominant mode of
inheritance [6], though a few follow autosomal recessive, X-linked
[10,13–16] and mitochondrial [16,17]. Recent studies had
suggested that the double and triple mutations identified in
sarcomere protein genes were found to be associated with early
onset of HCM [18,19].
Indian populations are reported to be more prone to cardiac
disorders, which might be due to their high effective population
size (Ne) and lifestyle, resulting a unique genetic structure [20–22].
Our previous study on cardiac Troponin I3 (TNNI3) [23,24] and
Troponin T2 (TNNT2) [25] in hypertrophic cardiomyopathy
(HCM), and cardiac actin (ACTC) [26], myosin binding protein C
(MyBPC3) [20], had revealed few variants, of which a 25 bp
deletion was found to be associated with both HCM and DCM in
India and south Asia [20]. Unfortunately, not many studies have
been conducted on Indian patients to explore the genetic etiology
of the disease, particularly with reference to the sarcomere protein
genes. Our aim in the present study is to investigate the genetic
variations in Troponin T (cTnT) gene, and its association with
DCM in South Indian cohorts.
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Figure 1. 1A-1M: Electropherograms showing SNPs of cTnT gene, observed in the present study on South Indian dilated
cardiomyopathy patients. Mutation sites were shown with arrows. Fig. 1A. R144W [rs483352832]: Electropherogram (arrow) showing a novel
missensemutation (R144W) at the nucleotide position g.14351 of human cTnT gene. The upper lane showing sequences of homozygous wild type allele
‘C’ in a control individual. The middle and the lower lanes were showing the sequences of heterozygous (C/T = Y) alleles in two individuals (a DCM
patient and his relative, respectively). Fig. 1B. G.A [IVS11-1G] [rs483352835]: Electropherogram (arrow) showing a variant at splice acceptor site of
human cTnT gene at nucleotide position g.16283, the electropherogram of a upper lane showing sequence of heterozygous (A/G=R) variant in a DCM
patient, the lower lane showing sequence of control individual having wild type allele ‘G’ (homozygous). Fig. 1C. N164N [rs483352833]:
Electropherogram (arrow) showing a novel synonumousmutation (N164) at the nucleotide position g.15304 of human cTnT gene in 2 DCM patients. The
upper lane shows the sequences of heterozygous (C/T = Y) transition in a DCM patient. The middle lane was the sequences of a control individual
showing the wild type allele ‘C’ (homozygous). The lower lane sequences showing heterozygous (C/T = Y) transition was from a 2nd DCM patient. Fig.
1D. [rs3729842]: Electropherogram showing (arrow) a single nucleotide polymorphism at the nucleotide position g.10636 (C/T = Y) in intron 5 of human
cTnT gene. The upper and the middle lanes were sequences showing heterozygous (C/T = Y) transition in DCM patients, the lower lane showing
homozygous wild type (C/C) allele in a control individual. Fig. 1E. [rs3729845]: Electropherogram showing (arrow) at the nucleotide position g.13011 of
human cTnT gene. The upper lane showing sequences of the heterozygous (A/G =R) transition, and the lower lane showing homozygous wild type (G/
G) allele of a control. Fig. 1F. [rs1104859]: Electropherogram showing (arrow) at the nucleotide position g.11643 (A/C=M) in Intron 11 of human cTnT
gene. The upper lane sequences showing the heterozygous (A/C=M) transversion, themiddle lane showing homozygous wild type (G/G), and the lower
lane sequences showing mutant homozygous (C/C) allele. Fig.1G. SNP-rs3729843: Electropherogram showing (arrow) a SNP at the nucleotide
position g.10822 (G/A=R) in intron 5 of human cTnT gene. The upper lane sequences showing mutant homozygous (A/A) allele. The middle lane
sequences showing heterozygous (G/A=R) transition allele, and the lower lane showing sequences of homozygous wild type (G/G) allele in a control
individual. Fig. 1H. [rs45576939]: Electropherogram showing (arrow) a novel mutation G.A at nucleotide position g.10370 in intron 4 of human cTnT
gene, the upper lane displaying homozygous mutant (A/A) allele, and the lower lane showing sequences of a wild type allele (G/G). Fig. 1I. [rs45576635]:
Electropherogram showing (arrow) a SNP at the nucleotide position g.14492 (C/T= Y) in intron 15 of human cTnT gene, the upper and the middle lanes
sequences displaying heterozygous (C/T=Y) transition, and the lower lane sequences showing homozygous wild type (C/C) allele. Fig. 1J. [rs3729547]:
Electropherogram showing (arrow) a polymorphic variant at the nucleotide position g.13424 of human cTnT gene, the upper lane displaying sequences
of the heterozygous (C/T = Y) transition, the middle lane sequences showing homozygous wild type (C/C) allele, and the lower lane displaying
sequences of the homozygous mutant (T/T) allele. Fig. 1K. [rs483352834]. Electropherogram (arrow) showing a novel mutation at the nucleotide
position g.15179 C.T in intron 11 of human cTnT gene, the upper lane displaying sequences of a DCM patient having heterozygous (C/T) transition, and
the lower lane exhibiting sequences of a control individual having homozygous wild type allele (C/C). Fig. 1L. K276K. [rs483352836]: Electropherogram
(arrow) exhibiting novel synonumous (K276) variant at the nucleotide position g.19429 of human cTnT gene in a DCM patient, the DCM patient
displaying heterozygous (G/A =R) transition. Fig. 1M. Sequence electropherogram showing (CTTCT) 5 bp Polymorphism.Ma. Presence of two copies
of CTTCT (Insertion/Insertion – homozygous insertion) in both the chromosomes,Mb. Absence of one copy of CTTCT (Deletion/Deletion – homozygous
deletion in both the chromosomes,Mc. Presence of 2 copies of CTTCT in one chromosome and presence of one copy of CTTCT in another chromosome
(Insertion/deletion – heterozygous allele). g.6626-30 (5 bp).
doi:10.1371/journal.pone.0101451.g001
A Novel Arginine to Tryptophan (R144W) Mutation in Troponin T (cTnT)
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e101451
T
a
b
le
1
.
T
o
ta
l
n
u
m
b
e
r
o
f
m
u
ta
ti
o
n
s
o
b
se
rv
e
d
in
T
ro
p
o
n
in
T
(c
Tn
T)
g
e
n
e
.
S
:N
O
C
h
ro
m
o
so
m
e
p
o
si
ti
o
n
G
e
n
o
m
ic
p
o
si
ti
o
n
M
a
jo
r
.
M
in
o
r
a
ll
e
le
L
o
ca
ti
o
n
S
N
P
R
e
fe
re
n
ce
A
A
C
h
a
n
g
e
N
o
v
e
l
P
o
ly
P
h
e
n
_
2
S
IF
T
P
re
d
ic
ti
o
n
s
C
O
N
/2
0
7
D
C
M
/1
4
7
1
1
2
0
1
3
4
1
2
7
6
-8
0
g
.6
6
2
6
-3
0
[5
b
p
]
In
tr
o
n
3
5
b
p
_
_
_
_
_
H
P
H
P
2
1
2
0
1
3
3
7
4
3
6
g
.1
0
3
7
0
G
.
A
In
tr
o
n
4
rs
4
5
5
7
6
9
3
9
_
_
_
_
_
0
1
3
1
2
0
1
3
3
7
1
7
0
g
.1
0
6
3
6
C
.
T
In
tr
o
n
5
rs
3
7
2
9
8
4
2
_
_
_
_
_
H
P
H
P
4
1
2
0
1
3
3
6
9
8
4
g
.1
0
8
2
2
G
.
A
In
tr
o
n
6
rs
3
7
2
9
8
4
3
_
_
_
_
_
H
P
H
P
5
1
2
0
1
3
3
5
8
9
9
g
.1
1
9
0
7
A
.
G
In
tr
o
n
7
rs
1
5
7
3
2
3
0
_
_
_
_
_
1
0
6
1
2
0
1
3
3
4
7
9
5
g
.1
3
0
1
1
G
.
A
Ex
o
n
8
rs
3
7
2
9
8
4
5
S6
9
S
_
_
_
_
0
2
7
1
2
0
1
3
3
4
3
8
2
g
.1
3
4
2
4
C
.
T
Ex
o
n
9
rs
3
7
2
9
5
4
7
I1
0
6
I
_
_
_
_
H
P
H
P
8
1
2
0
1
3
3
3
4
5
5
g
.1
4
3
5
1
C
.
T
Ex
o
n
1
0
rs
4
8
3
3
5
2
8
3
2
R
1
4
4
W
N
o
ve
l
D
am
ag
in
g
D
am
ag
in
g
P
at
h
o
g
e
n
ic
0
1
9
1
2
0
1
3
3
2
5
0
2
g
.1
5
3
0
4
C
.
T
Ex
o
n
1
1
rs
4
8
3
3
5
2
8
3
3
N
1
6
4
N
N
o
ve
l
_
_
_
0
2
1
0
1
2
0
1
3
3
2
6
0
3
g
.1
5
1
7
9
C
.
T
In
tr
o
n
1
1
rs
4
8
3
3
5
2
8
3
4
N
o
ve
l
N
o
ve
l
_
_
_
0
1
1
1
1
2
0
1
3
3
1
5
5
4
g
.1
6
2
5
2
[A
C
]
In
tr
o
n
1
1
rs
1
1
0
4
8
5
9
_
_
_
_
_
H
P
H
P
1
2
1
2
0
1
3
3
1
5
2
3
g
.1
6
2
8
3
G
.
A
In
tr
o
n
1
1
rs
4
8
3
3
5
2
8
3
5
SS
_
_
_
_
0
1
1
3
1
2
0
1
3
2
8
8
2
4
g
.1
8
9
8
2
C
.
T
In
tr
o
n
1
4
rs
2
2
7
5
8
6
3
_
_
_
_
_
P
P
1
4
1
2
0
1
3
2
8
7
0
5
g
.1
9
1
0
1
C
.
T
In
tr
o
n
1
5
rs
4
5
5
7
6
6
3
5
_
_
_
_
_
0
2
1
5
1
2
0
1
3
2
8
9
1
3
g
.1
8
8
9
3
C
.
T
In
tr
o
n
1
6
rs
4
5
5
0
9
6
9
5
_
_
_
_
_
0
4
1
6
1
2
0
1
3
2
8
3
7
7
g
.1
9
4
2
9
G
.
A
Ex
o
n
1
6
rs
4
8
3
3
5
2
8
3
6
K
2
7
6
K
_
_
_
_
0
2
*S
N
P
-
si
n
g
le
n
u
cl
e
o
ti
d
e
p
o
ly
m
o
rp
h
is
m
,
A
A
-A
m
in
o
A
ci
d
,
C
O
N
-
C
o
n
tr
o
ls
,
D
C
M
-
D
ila
te
d
ca
rd
io
m
yo
p
at
h
y,
SS
-
Sp
lic
e
Si
te
,
H
P
-H
ig
h
ly
P
o
ly
m
o
rp
h
ic
.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
1
0
1
4
5
1
.t
0
0
1
A Novel Arginine to Tryptophan (R144W) Mutation in Troponin T (cTnT)
PLOS ONE | www.plosone.org 3 July 2014 | Volume 9 | Issue 7 | e101451
Results
Sequencing of all the exons and the exon-intron boundaries
(5373 bp) of Troponin T2 (cTnT) gene in 147 DCM patients along
with 207 healthy controls had revealed a total of 15 SNPs and a
5 bp INDEL (Fig. 1A to 1M and Table 1).
Arginine to Tryptophan substitution at residue 144
(R144W) of cTnT gene
Of the 15 SNPs, a unique c.430 C.T transition (GenBank
No. NM_000364) in exon 10 of TNNT2 gene, identified in a 29
years old male DCM patient, is of great interest, as the mutation
replaces the highly conserved basic amino acid arginine at residue
Figure 2. The pedigree of a familial dilated cardiomyopathy patient (FDCM) having R144W mutation in the exon 10 of cardiac
Troponin T2 (cTnT) gene. Squares indicate males; circles, females; open symbols, normal individuals; solid symbols, affected individuals, Slanted
bars indicate deceased members of family. Plus signs indicate the presence of R144W mutation in cTnT; minus signs suggest the absence of mutation
R144W in cTnT.
doi:10.1371/journal.pone.0101451.g002
Figure 3. The amino acid arginine at residue 144 in human Troponin T (cTnT) is highly conserved across many species, including
mouse, rat, chicken, rabbit, sheep and bovine.
doi:10.1371/journal.pone.0101451.g003
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144 to polar-neutral tryptophan R144W [rs483352832] (Fig. 1A).
The R144W mutation has resulted with loss of restriction sites;
Mbil 19, Acil 19, BsrBl 19, AccBSl 19. Subsequent, screening of this
(R144W) mutation with available family members had revealed its
presence in three other individuals with DCM phenotype (Fig. 2).
However, this mutation was absent in 207 healthy unrelated
controls, and in 162 HCM patients [25]. Multiple alignment of the
amino acid with different species had revealed that the arginine at
144 in human cTnT is evolutionarily conserved across species;
including mammals, birds, reptiles, and nematode (Fig. 3).
While interacting with the family members of the proband, a
history of sudden cardiac deaths (SCD) in the family was noted.
Two individuals in the family, who were diagnosed with DCM,
had died due to severe congestive heart failure at the age of 45 and
25 years. However, a 66-year-old individual in the same family
with DCM having mild symptoms have also been noticed. Thus
indicating that the age of onset, and the severity of the disease are
highly variable within the family (Fig. 2 and, Table 2).
A novel splice acceptor site variant
We have also identified a novel splice acceptor site variant
(GRA) in intron 12 of cTnT gene [rs483352835], in a 63 years old
male DCM patient (Fig. 1B and, Table 1). This patient had both
dilated LV/LA, with EF 25%, global hypokinesia, grade III
systolic dysfunction, and IVS thinned out 7 mm. Unfortunately,
we were unable to get the family samples for additional analyses.
Two novel synonymous mutations
We further identified two novel synonymous mutations, N164N
(CRT; [rs483352833]) and K276K (GRA; [rs483352836]) in
cTnT gene (Fig. 1C and 1L, Table 1) exclusively in DCM. Of
which, N164N (Fig. 1C) was observed in 2 DCM (2/147= 1.4%)
patients with EF of 35% (a 35 year old female) and 30% (39 year
old male). The codon bias analysis had revealed a replacement of
more frequently used (wild type) codon (AAC: 64%) with a less
frequent one (AAT: 36%) (Table 3). The female patient showed
both dilated left ventricle and atrium, moderate mitral regurgita-
tion and moderate LV systolic dysfunction, while the male patient
showed LV dilation and moderate LV systolic dysfunction.
The K276K synonymous mutation (Fig. 1L; rs483352836) was
observed in 2 DCM patients (2/147= 1.4%), which replaces very
frequent codon (71%; AAG) with the less frequent codon (29%;
AAA) (Table 3). Though these two (N164N; K276K) mutations
were synonymous, its exclusive presence in dilated cardiomyop-
athy patients, illustrates its possible role in disease pathogenesis,
however, they need to be studied further.
Two intronic SNPs and their splicing patterns
We found two intronic SNPs of cTnT gene (GRA; g.10370_
[rs45576939] and CRT; g.15179- [rs483352834]), exclusively in
DCM patients. In silico analyses had predicted abnormal splicing
pattern (Table 4). The GRA variant was found to create an
additional binding site for hnRNP. K1K2 (Fig. 1H and, Table 4),
while the CR T variant was also causes drastic changes by altering
a total of 4 binding sites, 2 each in hnRNPs and SR proteins
(SRP20 ASF/SF2, SC35 and U2AF65) (Fig. 1K and, Table 4),
indicating its regulatory role, however, its clinical significance need
to be studied further.
Polymorphic SNPs
The chi-square and fisher exact probability test was done to test
the significance of polymorphic SNPs that were observed in this
study (Table 5). We have compared the genotype and allele
frequencies of these SNPs (NCBI database; www.ncbi.nlm.nih.
gov/projects/SNP/snp), with HapMap population’s data, (HER_-
ASIAN-PANEL; HER_HISP-PANEL; HER_CEPH-PANEL;
HER_YORUB-PANE).
a) SNP-rs3729842: The homozygous mutant allele was exclu-
sively observed in DCM and completely absent in the normal
controls and HapMap populations (ASW, CHB, LWK, MKK)
(Fig. 1D and, Fig. 4A and 4B). b) SNP-rs3729843: The allele
frequencies of DCM have matched only with MXL, TSI,
HapMap populations. The minor allele frequency was low in
CEU population, while it was completely absent in two (LWK and
YRI) HapMap populations (Fig. 1G and, Fig. 4A and 4B). c) SNP-
Table 4. The hn-RNP’s and SR-proteins binding site sequences in controls and DCM as predicted by ‘‘Splicing Rainbow’’ tool.
S. No
Chromosome Position/rs
number Position Location Splicing Rainbow & the binding site sequences
Normal Mutant
1 1201337436/rs45576939 g.10370(G.A) Intron 4 hnRNP.K1K2
CCCCATCCCCA CCCCATCCCCA
GCCCAT GCCCAT
_ TCCCCA
2 1201332603/rs483352834 g.15179 (C.T) Intron 10 SRP20
AGCTTCAGC _
ASF/SF2
CTGAACTCACCCATAAAGACC CTGAACTCACCCATAAAGACCACAAGT
C35S
GACCCAAGCTTCAG GACCACAA
U2AF65
_ TTTC
doi:10.1371/journal.pone.0101451.t004
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rs3729845: About 4%of heterozygous genotype was observed in
DCM, but it was completely absent in the controls, and two (CHB,
JPT) of the HapMap populations (Fig. 1E and, Fig. 4A and 4B). d)
SNP-rs3729547: The frequency of mutant homozygous allele was
7% in DCM as seen in Gujarati Indians GIH (Hap-map sample),
but it was as low as 3% in controls (Fig. 1J and, Fig. 4A and 4B). e)
SNP-rs1104859: The percentage of homozygous mutant allele was
13% in DCM, it was very low (6%) in controls. The frequency of
the heterozygous genotype was found to be high in CHB, CHD,
JPT, HapMap population’s (Fig. 1F and, Fig. 4 A and B).
Linkage disequilibrium
Plotting of all the SNPs observed in the present study had
revealed a strong linkage disequilibrium among three SNPs;
rs3729547 (C/T), rs3729843 (G/A), rs3729842 (C/T), (Fig. 1J, 1G
and, 1D and Table 1), respectively, which were about 2.0 kb
apart, in both HCM [21] and DCM (Fig. 5).
A 5 bp INDEL (CTTCT) polymorphism
A 5 bp (CTTCT) polymorphism (Fig. 1M;a-c) that results in
skipping of exon 4 of TNNT2 during splicing was not significant,
when compared to normal controls, it was found to be almost
equal in DCM however the deletion frequency was high in HCM
[25]. We have also further compared the 5 bp (CTTCT)
polymorphic frequencies in 2092 randomly selected individuals
belonging to 39 ethnic and endogamous populations from 19
states of India (Table 6), with DCM and HCM [25] (Fig. 6 A and
B).
Discussion
It has been shown initially that the mutations in the cTnT gene
are responsible for approximately 15% cases of familial hypertro-
phic cardiomyopathy (FHCM) [27]. However, subsequent studies
have identified cTnT gene mutations in familial dilated (FDCM)
[28], restrictive (RCM) [29], and left ventricular noncompaction
[30], cardiomyopathies. Interestingly, our study of cTnT gene in
147 dilated cardiomyopathy (DCM) patients against 207 ethnically
matched healthy controls had revealed a total of 15 SNPs and a
5 bp INDEL, including a novel heterozygous CRT at nucleotide
g.14351 in exon 10 of cTnT gene in a DCM patient. The mutation
had substituted polar-neutral amino acid tryptophan for a highly
conserved wild type basic amino acid arginine within the amino
terminal tail at residue 144 (R144W) of cTnT.
The R144W mutation was found to be within the tropomyosin-
binding domain of cTnT and alters the charge of the residue, so it
is expected to have a significant impact on the structure and
function of the protein. Later, screening of this mutation in all the
available members of a large four generations family had revealed
the presence of this heterozygous R144W mutation in three
affected individuals of the family (Fig. 2), suggesting that it is an
autosomal dominant trait. However, evaluation of 207 unrelated
healthy control individuals and 162 HCM patients [25] did not
show this (R144W) mutation.
The proband and 3 individuals positive for R144W mutation
had showed clinical features, that are typical for DCM,
specifically, left ventricular dilatation and depressed contractile
Figure 4. A. The genotype frequencies of SNPs (rs3729842, ra3729843, rs3729845, rs3729547, rs1104859) in the present study
were compared with HapMap samples (various populations). B. The Allele frequencies of SNPs (rs3729842, rs3729843, rs3729845, rs3729547,
rs1104859) in the present study were compared with HapMap samples (various populations). HapMap samples (various populations)- ASW, African
Ancestry in SW USA; CEU, CEPH Collection; CHB, Han Chinese in Beijing, China; CHD, Chinese in Metropolitan Denver, CO; GIH, Gujarati Indians in
Houston, TX; JPT, Japanese in Tokyo, Japan; LWK, Luhya in Webuye, Kenya; MEX, Mexican Ancestry in LA,CA; MKK, Maasai in Kinyawa, Kenya; TSI,
Toscani in Italia; YRI, Yoruba in Ibadan, Nigeria; CON-controls; HCM-hypertrophic cardiomyopathy; DCM-dilated cardiomyopathy.
doi:10.1371/journal.pone.0101451.g004
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function (Table 2). The sudden cardiac death (SCD) was also been
reported in the family, two individuals, who were diagnosed with
dilated cardiomyopathy (DCM), had died due to severe congestive
heart failure at the age of 45 and 25 years, these deceased
individuals were developed their cardiac condition in the second
and third decades of their life, respectively. However, a 66-year-
old individual in the same family has started having mild
symptoms only at his sixties (Fig. 2). Thus, the age of onset and
the severity of the disease are highly variable within the family,
suggesting that, in many cases, the scenario is more complex, if the
secondary etiological factors, such as lifestyle and environment are
involved (Fig. 2).
In addition, this amino acid tail residue arginine at 144 in
human cTnT is evolutionarily conserved across species, including
mouse, rat, chicken, quail, and nematode etc. (Fig. 3). It appears
that the amino-terminal tail of cTnT is essential for assembly and
anchoring of the troponin-tropomyosin complex onto the thin
filament [31–33]. The troponin-tropomyosin complex is a Ca2+
sensitive switch that regulates actin-myosin interaction. The
troponin complex (Troponins T, I, and C) is anchored to
tropomyosin predominantly by troponin T and to a lesser extent
by troponin I, and Troponin C interacts with these two troponins
T and I [33]. During systole, Ca2+ binds to cTnC and initiates
conformational changes of the troponin complex that attenuate
the inhibitory effect of cTnI. Results in the release of active sites of
the actin gene and this enables the myosin head of the thick
filament to interact with it and generate force. The Ca2+
concentration controls cTnC-cTnT interaction, which is important
for regulating sliding velocity between thick and thin filaments.
Interestingly, recent studies have proposed that cTnT is critical, not
only for the structural integrity of the troponin complex, but also
for sarcomere assembly and cardiac contractility [31–33].
In general, most of the reported mutations that were responsible
for the disease phenotype of dilated (DCM) were in the amino-
terminal tail of cTnT (exons 10 and 13) [34–36]. Moreover, no
mutations responsible for familial hypertrophic cardiomyopathies
have ever been identified in either of these exons, 10 and 13 [36].
Study of [37] some of the published mutations [(R131W [35] and
R141W [36] in exon 10), and (Lys 210 del [34,35], R205L [35] in
exon 13)], in the amino-terminal tail of TNNT2 gene reported to
be responsible for dilated cardiomyopathy (DCM); along with
other 4 thin filaments mutations, reconstituted with a 1:1 ratio of
mutant:wild type proteins, all showed reduced Ca2+ sensitivity of
activation in ATPase and motility assays, and all showed lower
maximum Ca2+ activation.
Integration of the cTnT mutations (R141W [36] and R205L
[35], into skinned guinea pig cardiac trabeculae also reduced Ca2+
sensitivity of force generation [37]. Therefore, diverse thin
filament DCM mutations appeared to affect different aspects of
regulatory function, nevertheless changing contractility in a
consistent manner. Further [37]stated that the DCM mutations
depressed myofibrillar function, an effect opposite to that of
HCM-causing thin filament mutations, and suggested that
decreased contractility might trigger pathways that ultimately lead
to the clinical phenotype. Generated knock-in mice [38] with a
reported mutation, K210-del [34,35] in exon 13 of cTnT gene, and
found that cardiac muscle fibers from mutant mice showed
significantly lower Ca2+ sensitivity in force generation than those
from wild type mice [38].
Compound heterozygosity (double and triple mutations) had
been reported to cause HCM phenotype [18,19]. Therefore, we
have further analyzed the patient and three of his family members
carrying R144W mutation having DCM phenotype with eight
other genes (b-MYH7, MYBPC3, TPM1, TNNI3, TTN, ACTC,
MYL2 and MYL3), to rule out compound heterozygosity. Our
analysis revealed that none of these 4 individuals showed any
disease causing mutations in eight of the above-mentioned genes,
except with few polymorphic variants. This had further confirmed
that the missense mutation R144W in cTnT gene is essentially
responsible for FDCM phenotype in our study family.
Of 15 SNPs, we have identified a novel splice acceptor site
mutation (GRA) at g.16283 in intron 12 (rs) of cTnT gene in a 63-
year-old male DCM patient (Table 1; Fig. 1B). Unfortunately, we
were unable to get the family samples for further analysis. The
splice acceptor site variant might create an alternative acceptor site
for splicing, which may results in the inclusion or exclusion of
amino acid (glutamine) or the complete skipping of the exon (9
nucleotides). As a result, this alternately spliced transcript might
form isoforms, which may be expressed in the human heart are
expected to be responsible for the disease phenotype; however, this
need to be studied further.
Interestingly, we also found a variant CRT at g.15179 in
intron11 of cTnT gene exclusively in a DCM, was predicted to
affect splicing. But we have unable to collect the family samples.
We have compared the genotype and allele frequencies of
polymorphic SNPs observed in this study with HapMap (NCBI
database; www.ncbi.nlm.nih.gov/projects/SNP/snp) populations
(HER_ASIAN-PANEL; HER_HISP-PANEL;HER_CEPH-PAN-
EL; HER_YORUB-PANE) (Fig.).
We have compared the 5 bp INDEL frequencies in 147 DCM
against 207 healthy controls along with 2092 randomly selected
individuals belonging to 39 ethnic and endogamous populations
inhabited in 19 states of India (Table 6). Our study revealed that
Figure 5. Three SNPs, [rs3729547 (C/T), rs3729843 (G/A),
rs3729842 (C/T)], (Table.1; Fig.1D, 1G, 1J) in TNNT2 gene
observed in the present study, which were about 2.0 kb apart
had shown high Linkage disequilibrium (LD). The bright red color
indicates very strong LD (LOD= 2D9= 1), white color no LD (LOD,2D9,
1), and pink (LOD=2D9,1) and blue (LOD,2D9=1) indicate interme-
diate LD (the standard color scheme is used to display LD). The values in
the LD blocks show the r2 values in percentages or multiplied by 100.
doi:10.1371/journal.pone.0101451.g005
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the 5 bp INDEL frequencies were found to be almost same in
DCM and the controls; nevertheless this 5 bp INDEL frequency
was high in South and the Northwest regions of Indian
populations, and HCM [25] (Fig. 6B).
In conclusion, we strongly suggest that the novel unique/private
R144W mutation identified in our present study is associated with
FDCM. The high level of endogamy in Indian populations along
with the influence of evolutionary forces such as genetic drift,
fragmentation and long-term isolation, has kept the Indian
populations diverse and distant [39]. Hence, the unique mutation
observed in this study is not surprising. Our study further suggests
that it is important to understand the fundamental genetics
(mutation) cause and its impact on disease phenotype, this will
certainly lead to adopt novel approaches for the diagnosis and
treatment of disease.
Materials and Methods
Ethical statement
All of the DNA samples analyzed in the present study were
derived from blood samples that were collected with the informed
written consent of the donors. The Institutional Ethics Committee
of Care Hospitals, Hyderabad, India; and the CSIR-Centre for
Cellular and Molecular Biology, Hyderabad, India, have approved
the study. This study conforms to the principles outlined in the
Declaration of Helsinki (WMA World Medical Association
Declaration of Helsinki). The study subjects were all South Indian
patients with dilated cardiomyopathy (DCM), diagnosed based on
the NYHA (New York Heart Association, 1994), and WHO (www.
who.int/cardiovascular_diseases) guidelines.
Inclusion criteria
Dilated cardiomyopathy (DCM) is characterized by left
ventricular enlargement (LVE), and when echocardiography
demonstrated a depressed systolic dysfunction with an ejection
fraction (LVEF) ,45–50% and/or fractional shortening ,25%.
Exclusion criteria
Patients with concomitant disease like; autoimmune disease,
cancer, as well as patients with coronary artery disease (CAD),
ventricular outflow tract obstructions and with advanced chronic
renal failure (CRF), were excluded.
Genetic analysis
We have sequenced all the exons, including the exon-intron
boundaries (5373 bp length) of Troponin T2 (cTnT) gene (Table
S1), of clinically well-characterized 147 DCM against ethnically
matched 207 healthy controls. (Text S1)
In silico analysis
To evaluate whether the SNPs observed exclusively in DCM
have any potential cause for the defect in splicing, we have
analyzed these sites with ASD Workbench wrapper (http://www.
ebi.ac.uk/asd-srv/wb.cgi) tools, such as poly-pyrimidine tract
(PPT), and branch-points (BP). The novel SNPs observed in this
study were subjected to identify the presence of PPT and BP
binding sites for splicing factors, and exonic splicing enhancers/
silencers (ESE/ESS) or intronic splicing enhancers/silencers (ISE/
ISS), respectively. Splicing Rainbow tool searches for the SR
proteins (serine/arginine-rich) as well as hnRNP motifs.
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